NCT01275222 2021-06-25
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Novartis
Phase 1/2 Completed
Clinical Trials
9 trialsNCT01248403 2020-01-29
AIO-STO-0111
Krankenhaus Nordwest
Phase 3 Completed
NCT00729482 2020-01-07
RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment
Asan Medical Center
Phase 2 Completed
NCT01514110 2019-04-02
Gastric Cancer RAD001 Study
Chinese University of Hong Kong
Phase 1/2 Completed
NCT00519324 2016-11-18
Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer
Novartis
Phase 2 Completed
NCT01099527 2015-12-29
A Trial of RAD001/Capecitabine in Refractory Gastric Cancer
Samsung Medical Center
Phase 1/2 Completed
NCT00879333 2015-11-03
GRANITE-1
Novartis
Phase 3 Completed
NCT00632268 2013-08-21
Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer
National Taiwan University Hospital
Phase 2 Completed
NCT01042782 2012-08-03
S387
Krankenhaus Nordwest
Phase 1 Completed